Before the general budget FY23, the market was bright today. Buying was seen in all the sector indices of BSE. Small, medium stocks have seen good gains. There was buying in IT, Realty, PSU shares. Auto stocks also rose ahead of the January auto numbers. Pharma, Media, Energy indices have also closed on the rise.
The biggest movement in these stocks today
Tata Motors | CMP: Rs 517.50 | Today the stock is up 4 per cent. While releasing the results for the third quarter ended December 31, 2021, Tata Motors has informed that the company has incurred a loss of Rs 1,516 crore during this period. The company had made a profit of Rs 2,906.5 crore in the third quarter of last year. The consolidated income of Jaguar Land Rover maker Tata Motors has seen a decline of 4.5 per cent year-on-year in the December quarter and stood at Rs 72,229 crore. Market experts believed that the company’s net loss during this period would be around Rs 2,200 crore. Let us inform that in the second quarter, the company had a loss of Rs 4,441.6 crore. The company has incurred losses for the fourth consecutive quarter. The company has suffered heavy losses due to the semiconductor shorting. It is worth noting that the auto industries of the whole world have faced shortage of semi conductor supply in the recent times, due to which the auto industry has suffered a lot.
Tata Steel Long Products, MMTC Today both the stocks are up per cent and 9 per cent. Today another government company has come in the bag of Tata Group. Tata Steel Long Products of Tata Group has taken another step towards inclusion of this company in its group by making the highest bid for the state-owned Neelachal Ispat Nigam Limited (NINL). CNBC-Awaaz’s Laxman Roy reports that Tata Steel Long Products has won the bid for NINL. The Tata Group company has won the bid to buy the company by making the highest bid of Rs 12,100 crore. The Long Products bid has also got CCEA approval.Tata Group company will buy 93.7% stake in NINL and sale of 93.7% stake in NINL has got CCEA approval.
According to the percentage stake of government companies in NINL, those companies will get money for their stake in this bid of Rs 12100 crore. MMTC will be the biggest beneficiary in this as it has the largest stake in NINL.
Reliance Industries | CMP: Rs 2,384.05 | Reliance has seen a rise of more than 2 percent today. Share price of Reliance Industries (RIL) rose nearly 2 per cent to Rs 2,374.35 on January 31 after foreign research firm CLSA downgraded its rating and target. ‘Buy’ rating and raised the target price from Rs 2,850 to Rs 2,955. “After the sharp fall, the company is now within 15 per cent of our conservative value and presently a good buy opportunity,” the rating agency said. is being made.”
Reliance on January 21 reported a consolidated profit of Rs 18,549 crore for the quarter ended December 2021, up 42 per cent from Rs 13,101 crore in the same quarter a year ago. The company had a profit of Rs 13,680 crore in the September 2021 quarter.
Britannia Industries | CMP: Rs 3,544.20 | Today this stock has closed in green mark. The company’s profit in the third quarter stood at Rs 371 crore, down 19 per cent year-on-year. Let us inform that in the same quarter last year, the company’s profit was Rs 456 crore. Macquarie has given a target of Rs 4,000 for this stock by giving Neutral Rating.
Sun Pharma | CMP: Rs 834 | Today this stock has also closed in the green mark. Sun Pharma has released its third quarter results for the financial year 2021-22 ended 31st December 2021. The company’s profit in the third quarter stood at Rs 2060 crore. Whereas CNBC TV18’s poll had estimated it to be at Rs 1760 crore. At the same time, in its last financial year i.e. FY 2020-21, the company’s profit stood at Rs 1858 crore. The company’s income in the third quarter stood at Rs 9863 crore. Whereas in the poll of CNBC TV-18, it was estimated to be at Rs 9549 crores. At the same time, in its last financial year i.e. FY 2020-21, the company’s income stood at Rs 8837 crore. The company’s EBITDA has increased from Rs 2,406 crore to Rs 2606 crore on a year-on-year basis. Although it was estimated to be at Rs 2545 crore. On a year-on-year basis, the Ebit margin of SUN PHARMA has declined from 27.2 per cent to 26.4 per cent. Whereas it was estimated to be at 26.7%. The company has also announced an interim dividend of Rs 7 per share for the financial year 2021-22.
,